Skip to main content

and
  1. No Access

    Article

    A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting

    Patient-reported outcomes (PROs) may help patients and clinicians in selecting disease-modifying therapies (DMTs) for multiple sclerosis (MS).

    R. Lanzillo, M. Sparaco, L. Lavorgna, L. Carmisciano in Neurological Sciences (2020)